Enabling drug synergy and drug dose response assays
14 July 2021
Developing assays to assess the effectiveness of drug combinations or different doses of single drugs in vitro is an increasingly important area of drug and anticancer therapy research. In developing high throughput assays, researchers face the double challenge of quickly dispensing both viable cells and drug combinations. In particular, the dispensing of two or more compounds to create a dose-response matrix can be both labour intensive and compound expensive.